日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p

撤稿声明:CircPSMC3通过海绵吸附miR-296-5p,作为竞争性内源RNA抑制胃癌细胞的增殖和转移。

Rong, Dawei; Lu, Chen; Zhang, Betty; Fu, Kai; Zhao, Shuli; Tang, Weiwei; Cao, Hongyong

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway

GLIS1 干预通过靶向 SGK1-STAT3-PD1 通路增强抗 PD-1 疗法治疗肝细胞癌的效果。

Rong, Dawei; Wang, Yuliang; Liu, Li; Cao, Hengsong; Huang, Tian; Liu, Hanyuan; Hao, Xiaopei; Sun, Guangshun; Sun, Guoqiang; Zheng, Zhiying; Kang, Junwei; Xia, Yongxiang; Chen, Ziyi; Tang, Weiwei; Wang, Xuehao

Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective study

瑞戈非尼联合免疫检查点抑制剂疗法作为晚期肝细胞癌患者二线和三线治疗方案的疗效和安全性:一项回顾性研究

Zhao, Jie; Guo, Yongzhong; Feng, Tianshuo; Rong, Dawei; Kong, Xiangyi; Huang, Tian; Lopez-Lopez, Victor; Yarmohammadi, Hooman; Sakamoto, Yoshihiro; Zhu, Deming; Yao, Aihua; Xia, Yongxiang

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing

基于单细胞RNA测序的研究表明,APOC1抑制剂可通过铁死亡途径促进M2型巨噬细胞向M1型巨噬细胞转化,并增强抗PD-1免疫疗法在肝细胞癌中的疗效。

Hao, Xiaopei; Zheng, Zhiying; Liu, Hanyuan; Zhang, Yao; Kang, Junwei; Kong, Xiangyi; Rong, Dawei; Sun, Guangshun; Sun, Guoqiang; Liu, Li; Yu, Haibo; Tang, Weiwei; Wang, Xuehao

Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy

巨噬细胞 GSK3β 缺陷可抑制肝细胞癌的进展并增强抗 PD-1 免疫疗法的敏感性

Sun, Guangshun; Liu, Hanyuan; Zhao, Jie; Zhang, Jinyu; Huang, Tian; Sun, Guoqiang; Zhao, Siqi; Zhang, Zihao; Cao, Hengsong; Rong, Dawei; Kong, Xiangyi; Ji, Qinghua; Liu, Li; Wang, Xuehao; Tang, Weiwei; Xia, Yongxiang

Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies

肿瘤微环境及其对胆管癌抗肿瘤免疫的影响:新型疗法的未来展望

Cao, Hengsong; Huang, Tian; Dai, Mingrui; Kong, Xiangyi; Liu, Hanyuan; Zheng, Zhiying; Sun, Guoqiang; Sun, Guangshun; Rong, Dawei; Jin, Zehua; Tang, Weiwei; Xia, Yongxiang

Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma.

GUSB 过度表达导致肝细胞癌对 PD-1 抑制剂产生原发性耐药

Kong Xiangyi, Zheng Zhiying, Song Guoxin, Zhang Zihao, Liu Hanyuan, Kang Junwei, Sun Guoqiang, Sun Guangshun, Huang Tian, Li Xiao, Rong Dawei, Wang Ke, Tang Weiwei, Xia Yongxiang

Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway

癌相关成纤维细胞外泌体通过 circZFR 靶向信号转导和转录激活因子 (STAT3)/核因子-κB (NF-κB) 通路,促进肝细胞癌对顺铂的化疗耐药性。

Zhou, Yun; Tang, Weiwei; Zhuo, Han; Zhu, Deming; Rong, Dawei; Sun, Jin; Song, Jinhua

A 3D multi-modal intelligent intervention system using electromagnetic navigation for real-time positioning and ultrasound images: a prospective randomized controlled trial

一种利用电磁导航进行实时定位和超声成像的三维多模态智能介入系统:一项前瞻性随机对照试验

Tang, Weiwei; Zhou, Yun; Zhao, Hui; Sun, Guangshun; Rong, Dawei; Li, Zhitao; Hu, Meng; Han, Liu; He, Xu; Zhao, Suming; Chen, Xiaoyang; Li, Zhongming; Yuan, Hongxin; Chen, Songwang; Wang, Qian; Li, Zhouxiao; Gu, Jianping; Wang, Xuehao; Song, Jinhua

m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression

m6A修饰circHPS5与HMGA2表达介导的肝细胞癌进展

Rong, Dawei; Wu, Fan; Lu, Chen; Sun, Guangshun; Shi, Xiaoli; Chen, Xiaoyuan; Dai, Yongjiu; Zhong, Weizhe; Hao, Xiaopei; Zhou, Jinren; Xia, Yongxiang; Tang, Weiwei; Wang, Xuehao